Abstract
The implementation of minimally invasive esophagectomy has gained widespread acceptance following the publication of randomized controlled trials demonstrating reduced pulmonary complications and shorter hospital stays. However, variability in reported anastomotic leak rates and differences in selected trial endpoints have raised questions regarding how best to balance innovation with patient safety during the adoption of new surgical techniques. This Lessons Learned article reflects on the ethical and clinical considerations surrounding the transition toward fully minimally invasive esophagectomy when excellent outcomes have been achieved with hybrid or open approaches in high-volume centers. Drawing on our institutional experience with a modified hybrid Ivor-Lewis technique, combining thoracoscopic lymphadenectomy with open reconstruction, we discuss how stepwise integration of minimally invasive surgical steps may preserve key postoperative outcomes during the learning curve. We argue that institutional performance and outcomes with major clinical impact, particularly anastomotic integrity and major complications, should play a central role in guiding the pace and modality of innovation adoption. Surgical progress should be driven by real-world results and structured learning pathways, ensuring that advances in esophageal surgery remain patient-centered and ethically sound.